Some of the key findings from our hirsutism treatment market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.
Get a FREE sample now!
Global hirsutism treatment industry overview
High level of androgen is one of the major causes of excess hair growth in women. As birth control pills suppress androgen levels, it has emerged as the first line of medication for treating hirsutism. Combination birth control pills reduce levels of free androgen by increasing the sex-hormone-binding globulin. Oral contraceptives such as norethindrone acetate, desogestrel, gestodene, ethynodiol diacetate, and norgestimate are normally preferred for the treatment as these contain progestin with low androgenic activity. The increasing use of androgen-blocking birth control pills is identified as a key trend that will positively impact the growth of the hirsutism treatment market.
The rapid onset of modernization and the adoption of poor lifestyle habits have resulted in increased incidences of androgen-related disorders such as PCOS in women. PCOS is a chronic condition associated with menstrual irregularities which cause high androgen secretion and thereby increases the chances of hirsutism. Women suffering from diabetes mellitus are also prone to hirsutism. Moreover, the adverse effects of certain medications such as anabolic steroids, osteoporosis and endometriosis drugs, and natural supplements such as DHEA and androstenedione may also cause hirsutism. The growing cases of associated risk factors and the increased use of androgen-related drugs will increase the chances of hirsutism. Such factors will boost the demand for hirsutism treatment, driving the growth of hirsutism treatment market at a CAGR of almost 14% during the forecast period.
Top hirsutism treatment companies covered in the market research report
The global hirsutism treatment market is moderately fragmented. To help clients improve their market position, the report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, the market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of the upcoming growth opportunities.
The report offers a detailed analysis of several leading companies including:
- ALLERGAN
- Bayer AG
- Lumenis
- Merck & Co., Inc.
- Pfizer Inc.
Hirsutism treatment market segmentation based on the type
The medications segment will account for the highest hirsutism treatment market share in the coming years. The increasing prevalence of hirsutism-associated risk factors and the presence of symptomatic combination drugs will drive market growth in the segment. The report provides an accurate prediction of the contribution of all the segments to the growth of the hirsutism treatment market size.
Hirsutism treatment market segmentation based on geographic region
- Asia
- Europe
- North America
- ROW
With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the hirsutism treatment market throughout the forecast period. The increased cases of chronic conditions, the development of innovative treatment methods, and the rising disposable income of individuals will drive the need for hirsutism treatment in the region.
Key highlights of the global hirsutism treatment market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the hirsutism treatment market during the next five years
- Precise estimation of the global hirsutism treatment market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of the companies
We can help! Our analysts can customize the market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Medications - Market size and forecast 2018-2023
- Procedures - Market size and forecast 2018-2023
- Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 12: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- ALLERGAN
- Bayer AG
- Lumenis
- Merck & Co., Inc.
- Pfizer Inc.
PART 13: APPENDIX
- Research methodology
- List of abbreviations
PART 14: EXPLORE TECHNAVIO